CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)
Beginning Balances (in shares) at Dec. 31, 2017		22,934,403
Beginning Balance at Dec. 31, 2017	$ 364,571	$ 22,934	$ 165,288	$ 178,969	$ (2,620)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
NET INCOME	11,813			11,813
Other Comprehensive Income (Loss)	(9,218)				(9,218)
Cash Dividends	(3,440)			(3,440)
Issuance of Common Stock for:
Restricted Share Grants (in shares)		34,410
Restricted Share Grants	279	$ 35	244
Ending Balances (in shares) at Mar. 31, 2018		22,968,813
Ending Balance at Mar. 31, 2018	364,005	$ 22,969	165,532	187,342	(11,838)
Beginning Balances (in shares) at Dec. 31, 2018		24,967,458
Beginning Balance at Dec. 31, 2018	458,640	$ 24,967	229,347	211,424	(7,098)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
NET INCOME	15,067			15,067
Other Comprehensive Income (Loss)	9,414				9,414
Cash Dividends	(4,245)			(4,245)
Issuance of Common Stock for:
Restricted Share Grants (in shares)		24,780
Restricted Share Grants	311	$ 25	286
Ending Balances (in shares) at Mar. 31, 2019		24,992,238
Ending Balance at Mar. 31, 2019	$ 479,187	$ 24,992	$ 229,633	$ 222,246	$ 2,316